1. Home
  2. AUUD vs ONCO Comparison

AUUD vs ONCO Comparison

Compare AUUD & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Auddia Inc.

AUUD

Auddia Inc.

N/A

Current Price

$0.80

Market Cap

2.3M

Sector

Technology

ML Signal

N/A

Logo Onconetix Inc.

ONCO

Onconetix Inc.

N/A

Current Price

$0.54

Market Cap

2.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AUUD
ONCO
Founded
2012
2018
Country
United States
United States
Employees
6
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3M
2.3M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
AUUD
ONCO
Price
$0.80
$0.54
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.4M
539.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,524,116.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
4217.31
52 Week Low
$0.21
$0.05
52 Week High
$7.29
$7.65

Technical Indicators

Market Signals
Indicator
AUUD
ONCO
Relative Strength Index (RSI) 46.98 33.90
Support Level $0.66 $0.07
Resistance Level $1.20 $0.95
Average True Range (ATR) 0.09 0.10
MACD -0.01 0.01
Stochastic Oscillator 24.26 19.66

Price Performance

Historical Comparison
AUUD
ONCO

About AUUD Auddia Inc.

Auddia Inc is a United States-based company. It operates through its proprietary AI platform for audio and is reinventing not only how consumers engage with AM/FM radio, podcasts, and other audio content but also how artists and labels promote their music and gain access to mainstream radio audiences. The group Discovr Radio is the first music-promotion platform to deliver artists guaranteed exposure to radio listeners. Its flagship audio superapp, called faidr, delivers multiple industry firsts, including: Ad-free listening on any AM/FM radio station, Content skipping across any AM/FM station, One-touch skipping of entire podcast ad breaks, and Integrated artist discovery experiences.

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

Share on Social Networks: